Korea Investment Partners

Established in 1986, Korea Investment Partners is a prominent venture capital firm headquartered in Seoul. With over three decades of experience, the company invests globally in innovative startups across various sectors, including technology, healthcare, and manufacturing. Notable investments include Kakao, Naver, YG Entertainment, and Didi Chuxing. The firm manages multiple funds with total assets under management exceeding US$1.8 billion.

Jihyun An

Principal of Venture Group 2

Shane Ang

Investor

In Jae Baek

Principal of Venture Group 1

Yer Hyun Baek

President

Haksung Chang

Managing Director and Head, PE

Yan Hao Chong

Principal, Singapore

Yeong Mok Gil

Managing Director

Hudson Kyungshik Ho

Investor

Jingzhi Hu

Managing Partner

Mahn Soon Hwang

Investor

Man Soon Hwang

CEO

Joon Hyun

Managing Director

Sang Hyuk Jang

Principal

Leah Jiang

Investor

Soon Ouk Jung

Executive Director of Venture Group 2

Seung-hi Kang

Principal

Kun Ho Kim

Principal

Jae Hong Kim

Managing Director

Hwa Young Kim

Senior Associate

Dong Yeob Kim

Investor

Chang Ho Kim

General Manager

Yunjoon Kim Ph.D

Managing Director of Venture Group 1

Yong Jae Kim

Executive Director

Min Q Kim

Director

Kim Jong -hyun

Director

Hee Jin Kim

Director of Venture Group 1

SuChan Kwon

Senior Associate

Su Chan Kwon

Principal of Venture Group 2

Ji soo Lee

Director of Venture Group 1

Sang Jin Lee

Principal

Young Tak Lee

Principal

Sangwoo Lee

Managing Director

Michael Lee

Executive Director of Venture Group 1

Sangjoon Park

Investor

Min Sik Park

Managing Director

Deok Joon Shin

Director

Deok Jun Shin

Managing Director

Dong Hyun Song Ph.D

Executive Director of Venture Group 1

Benjamin Hyun Mok Song

Principal

Ping Wang

Associate Partner

Jerry Xu

Director and Principal

Clara Yoon

Principal

Past deals in Growth Stage

Guhada

Series B in 2025
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting European boutiques with domestic markets, including shopping malls and fashion vertical commerce. The company specializes in supplying high-demand luxury items and contemporary products, offering a diverse selection of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada enables customers to access genuine luxury products at competitive prices, enhancing the shopping experience for those seeking premium fashion items.

ActiveOn

Series B in 2025
ActiveOn, a company specializing in cosmetic materials and microcapsules, including preservative alternatives, spares no effort to share happiness with neighbors, with the objective that happy employees generate the greatest goods.

Gangnam Unni

Series C in 2025
Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medical information and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries. The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases. As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.

Healing Paper

Series C in 2025
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

Pin Therapeutics

Series C in 2024
Pin Therapeutics is a biotechnology company developing therapeutic products that target disease-causing proteins for immune diseases, cancer, and aging-related conditions. It employs protein degradation systems to break down these proteins.

RideFlux

Series B in 2024
RideFlux is a South Korean self-driving software company focused on safe and reliable autonomous transportation. The firm develops autonomous driving software and pilot services, including remote vehicle control and high-precision map operation, to enable safe, efficient mobility. Founded in 2018, RideFlux conducts development and testing in Jeju Island, leveraging its varied road environments and weather conditions to advance urban autonomy. The company aims to provide integrated software and services that support autonomous driving for consumer and mobility services, emphasizing safety and reliability in autonomous transportation.

LESSENGERS

Series C in 2024
LESSENGERS specializes in the manufacturing of optical interconnect solutions that utilize polymer wires for optical waveguides in three-dimensional space. The company designs innovative products that facilitate cost-effective direct optical coupling without the need for lens optics. These solutions are particularly suited for data center applications, enabling the connection of two points requiring optical signal transmission in communication devices. By employing transparent polymer wires, LESSENGERS provides effective wiring options for optical transceiver modules and photonics devices. This technology helps companies enhance their communication products and deliver seamless network connectivity to their users.

MicrobiotiX

Series B in 2024
MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases, and pursues therapeutic diagnostic technologies to enable microbiome-focused treatments. The company’s platform supports safe gastrointestinal microbiota transplant in a medical setting, formulates fecal microbiota transplant capsules for oral administration, and conducts research and development of bacteriophages, with the aim of delivering convenient, economical therapies that reduce infection risk. Through these approaches, MicrobiotiX seeks to advance microbiome and phage therapies for difficult-to-treat conditions, integrating diagnostics with therapeutics to streamline patient care.

Bio Design Lab

Series B in 2024
Bio Design Lab is a biotechnology company focused on the development of biopharmaceutical products, specifically in the areas of gene, cell, and immunotherapies. The company employs systems-level genetic and genomic design strategies to create potent drugs aimed at addressing a range of diseases. By utilizing advanced methodologies, Bio Design Lab aims to enhance the efficiency of drug development processes for healthcare organizations, ultimately contributing to the creation of effective therapeutic solutions.

FIRMMIT

Series B in 2024
FIRMMIT optimizes agricultural growth data through secure collection and analysis of ag-tech data, aiming to enhance crop yields and promote sustainable farming practices.

AIDIN ROBOTICS

Series B in 2024
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.

Xpanner

Series B in 2024
Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.

Inter X

Series B in 2024
Inter X is an industrial AI and big data analysis company.

EYEQ Lab

Series B in 2024
EYEQ Lab is an engineering firm that develops and manufactures power semiconductors, offering end-to-end development and manufacturing capabilities for power semiconductor technologies. The company supports applications in solar energy, autonomous vehicles, high-speed charging, medical equipment, and aerospace. By applying specialized engineering expertise, EYEQ Lab aims to advance power system performance, efficiency, and reliability across customer projects.

LiveIn

Series B in 2024
LiveIn is a leading online marketplace specializing in student accommodation, boasting over 20,000 listings. The company operates a real estate brokerage platform designed to assist young individuals with limited economic resources in finding affordable rental housing. LiveIn prioritizes the well-being of its clients and workers, ensuring a responsible approach to their services. The platform provides a seamless rental search experience, featuring fully furnished rooms equipped with complimentary WiFi, weekly housekeeping, and maintenance services. This enables customers to easily locate and book rental properties in their vicinity, making the process efficient and user-friendly.

Juexin Technology

Series B in 2024
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.

DYNE Medical Group

Series B in 2024
DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing innovative manufacturing technologies that incorporate reusable flexible endoscopes, utilizing a unique optimization design and ultra-precision processing. This advanced approach aims to enhance the effectiveness of endoscopic procedures, facilitating minimally invasive treatments for patients. Additionally, DYNE Medical Group is committed to providing AI-based cancer diagnostics, further supporting healthcare professionals in delivering improved patient care.

​Orange Square

Series B in 2024
​Orange Square is a fintech platform that offers prepaid cards and mobile wallets for travelers.

CareMedi

Series B in 2023
CareMedi is a healthcare company specializing in the development of innovative medical devices, particularly a wearable drug pump designed to enhance the quality of life for individuals with diabetes. The company's platform offers a range of healthcare products, including medical equipment, nebulizers, aspirators, and massagers. By enabling consumers to conveniently order these products from home, CareMedi aims to improve overall lifestyle and health outcomes for its users.

Getcha

Series B in 2023
Getcha is a comprehensive car purchasing and rental service that operates an online comparison shopping platform. The company facilitates the buying process by connecting consumers with sellers and providing access to a network of dealerships. Getcha enables users to obtain multiple price quotes, ensuring transparency in transaction pricing. In addition to car purchases, the company offers long-term rentals, leasing options, test rides, and car consulting services, catering to a wide range of automotive needs. By streamlining the car buying experience, Getcha empowers customers with the information they need to make informed decisions while allowing sellers to focus on motivated buyers.

Brexogen

Series C in 2023
Brexogen is a biotechnology company focused on cell therapy research and development. It specializes in creating optimized parental cells for exosome production, aiming to treat incurable diseases through stem cell exosomes.

FuriosaAI

Series C in 2023
FuriosaAI delivers the performance for real-time AI services while achieving energy efficiency for the lowest operation cost at scale. They build the entire product on a solid core foundation because AI chips on the ground are doomed to fail when it comes to addressing the complex and rapidly changing requirement metrics of hyper scalers and enterprises.

Levit

Series B in 2023
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience

Jenfi

Funding Round in 2023
Jenfi is a financial technology company founded by Jeffrey Liu and Justin Louie, specializing in revenue-based financing for digital-native businesses in Southeast Asia. The company offers a service known as Growth Capital as a Service (GCaaS), which provides non-dilutive capital of up to US$1,000,000 to help businesses scale their marketing, inventory, and growth initiatives. Jenfi utilizes a proprietary risk assessment engine to evaluate both the creditworthiness of businesses and their marketing growth efficiency, ensuring that financing options are flexible and customized to meet the specific needs of each client. The platform has supported hundreds of digital-native companies, including various B2B and SaaS startups. Prior to founding Jenfi, Liu and Louie successfully developed and exited the fitness subscription service GuavaPass.

S-Alpha Therapeutics

Series B in 2023
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, established in 2019. It specializes in researching and developing health applications and platform technologies that leverage digital devices for the treatment of various diseases. The company’s product pipeline includes SAT-001, an application focused on ophthalmology for eye disease treatment; SAT-002, which addresses neurological conditions; SAT-003, designed for oncology to support cancer patients in their recovery; and SAT-008, aimed at public crises to address social issues. In addition to its health applications, S-Alpha Therapeutics also develops therapeutic devices, striving to provide innovative solutions for unmet medical needs across multiple therapeutic areas, including ophthalmology, neuropsychiatry, and cancer.

Guhada

Series B in 2023
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting European boutiques with domestic markets, including shopping malls and fashion vertical commerce. The company specializes in supplying high-demand luxury items and contemporary products, offering a diverse selection of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada enables customers to access genuine luxury products at competitive prices, enhancing the shopping experience for those seeking premium fashion items.

VSI

Series B in 2023
VSI is a semiconductor manufacturer specializing in automotive networking technologies. It develops essential semiconductors for next-generation automotive applications, focusing on products crucial to autonomous vehicle functionality.

Kneader

Series B in 2022
Kneader operates an online recruitment platform specializing in temporary and part-time job matching. It offers career management services for job seekers to create profiles highlighting their skills, education, and experience, and apply for jobs. Employers can post jobs, view candidate profiles, and hire candidates through the platform.

Innospace

Series B in 2022
Innospace Co Ltd is an aerospace and defense company that specializes in the development and provision of launch services for small satellites. The company focuses on creating hybrid rocket-powered small satellite launch vehicles, which are designed to deliver low-cost, low-latency, and eco-friendly launch solutions. By leveraging innovative technology, Innospace aims to establish a reliable presence in the small satellite market, offering services that meet the growing demands of satellite deployment while emphasizing sustainable practices.

NRISE

Series B in 2022
NRISE is a company focused on developing innovative software applications that enhance communication and content sharing among users. It offers a range of services, including MOCI and WIPPY, which are designed to facilitate connections between individuals and provide access to diverse content. In addition to social media services, NRISE has created an application specifically for home workouts, integrating fitness with social interaction. Through these applications, the company aims to bring users the joy of communication while promoting engagement with various types of content.

SuperBin

Series B in 2022
SuperBin Co., founded in 2015 and headquartered in Seongnam-si, South Korea, specializes in the development of Nephron, an advanced circular resources collection robot. This innovative robot employs artificial intelligence to autonomously identify, sort, collect, and process waste materials, specifically targeting plastics and aluminum cans. SuperBin aims to foster a culture of recycling and sustainable growth by incentivizing users with financial rewards for their recycling efforts. Through its technology, the company seeks to promote the value of circulating resources and encourage a collective commitment to environmental responsibility.

Oncobix

Series B in 2022
Oncobix is a drug development company focused on creating innovative treatments for rare and incurable diseases that are difficult to address with current medical practices. The company has developed a novel compound, represented by a specific chemical formula or its salts, along with a pharmaceutical composition aimed at treating conditions such as lung cancer. By prioritizing the well-being of patients, Oncobix seeks to provide new therapeutic options that can significantly impact the treatment landscape for challenging medical conditions.

Apposter

Series B in 2022
Apposter is a South Korean company specializing in interactive solutions. It offers UI development, app development, and mobile business consultancy services to its clients. The company has released several enterprise-level mobile apps and solutions.

21gram

Series B in 2022
21gram is a company that specializes in pet funeral services, focusing on connecting pet owners with reputable companion animal funeral homes. It offers a platform that allows users to search for and book services based on location, costs, and specific requirements. Additionally, 21gram provides counseling services to assist customers in navigating the process of honoring their pets after passing. By streamlining the search for pet funeral homes and ensuring a respectful farewell, the company aims to support pet owners during a challenging time.

Gitple

Series B in 2022
Gitple is a technology company that develops an interactive customer support platform, offering customer experience as a cloud service. Its platform enables businesses to integrate customer service functionality into mobile applications, facilitating collaborative responses from chatbots and agents, thereby enhancing brand image and driving sales.

Genesis Lab

Series B in 2022
Genesis Lab, Inc. is a technology company based in Seoul, South Korea, founded in 2017, specializing in the development of artificial intelligence behavior analysis engines. The company offers a range of innovative products, including Viewinter.ai, a non-verbal behavior analysis tool designed to assist job seekers in training for video interviews. Additionally, Genesis Lab provides Genesis Drive, a solution that monitors driver drowsiness and distractions while detecting the emotions and behaviors of both drivers and passengers to enhance interactions and services. The Genesis Emotion AI SDK/API allows various industries to implement emotion recognition technology into their applications. The company also develops mobile applications, such as OREO, which humorously analyzes emotions, age, and gender from photos, and EMO, a gaming app that enables users to express emotions through facial mimicry. Overall, Genesis Lab aims to improve human-machine communication through its advanced AI technologies.

CONTEC

Series C in 2022
CONTEC is providing ground station services, satellite image processing, and application services. The company's ground station network supports VHF, UHF, S-Band, and X-Band frequencies for TT&C via high-performance receivers for high data rate reception. They especially focus on applications for urban change detection of smart cities and aim to provide the best service possible for local governments and therefore contribute to urban development. Contec's main goal of building a global ground station network and operating its own Earth observation satellites.

Genieworks

Series B in 2022
Genieworks is an innovative company focused on developing a software platform tailored for e-commerce, advertising, and online-to-offline (o2o) services. The platform uniquely integrates self-marketing capabilities, open market commerce, and on-demand car concierge services through a range of applications. This technology enables businesses to effectively engage in promotional marketing, build commerce networks, and develop smart tour technology-based solutions. By combining creative ideas with advanced technology, Genieworks aims to transform how businesses operate in the digital landscape.

Toffee Pie

Series B in 2022
Toffee Pie is a retailer of bras in different sizes. They develop bras of different sizes and shapes, enabling customers with different needs to access suitable underwear. They offer a large-cup underwear brand that researches and develops bras for big-breasted girls.

HappyEasyGo

Series C in 2022
HappyEasyGo is an Indian online travel company offering affordable flight tickets from various airlines like IndiGo, Jet Airways, GoAir, SpiceJet, AirAsia, Vistara, and Air India. It also provides verified hotel bookings and special offers on flight tickets.

Jaranda

Series B in 2022
Jaranda operates an online platform based in Seoul, South Korea, that connects teachers, parents, and students. It aims to bridge the information asymmetry in childcare and education by providing a learning sheet for working parents, helping children discover suitable educational experiences.

Yibai Technology

Series B in 2022
Yibai Technology is a specialist in healthcare-based software-as-a-service.

Catch Table

Series C in 2022
Catch Table is a restaurant reservation management platform that offers a streamlined solution for booking tables in various dining establishments. It enables customers to make real-time reservations while filtering options based on specific criteria, including date, number of guests, price range, food category, and table type. Additionally, the platform provides useful information about amenities like valet parking and corkage services, enhancing the overall dining experience. By facilitating these features, Catch Table aims to simplify the reservation process for customers and improve operational efficiency for restaurants.

Adriel

Series B in 2022
Adriel is a provider of a marketing analytics and reporting platform that consolidates data from multiple advertising and marketing platforms to deliver unified insights. The platform automates the creation of daily, weekly, and monthly reports, monitors budget spend, and reduces errors in budget planning, enabling marketing teams to improve efficiency and accuracy. It centralizes data and communications into a single dashboard, offering real-time performance signals, cross-channel insights, and actionable recommendations to optimize campaigns and budget allocation. The solution supports optimization of paid advertising by highlighting trends and redirecting spend toward higher-performing creatives and channels. Adriel serves thousands of companies globally, helping clients understand campaign performance and maximize return on investment.

Rizzle AI

Series B in 2022
Rizzle AI is a company that specializes in transforming text content and podcasts into engaging videos using advanced artificial intelligence technology. By leveraging professional images and natural-sounding voices, Rizzle helps businesses and publishers captivate audiences, expand their reach, and drive content monetization. The platform offers tools for easy video creation, custom thumbnails, short-form content, and interactive maps, making storytelling straightforward and impactful. Key differentiators include end-to-end simplicity in video production, access to premium media through partnerships with various high-quality providers, extensive syndication opportunities, and flexible service options tailored to individual needs. Rizzle AI's solutions are designed to streamline video production, allowing teams to focus on strategy, creativity, and revenue generation.

Dr.Diary

Series B in 2022
Founded in 2017, Dr.Diary is a South Korean company specializing in diabetes management solutions. Its flagship application helps users monitor blood sugar levels, track exercise routines and food intake, receive personalized health insights, and communicate with healthcare professionals.

Pin Therapeutics

Series B in 2022
Pin Therapeutics is a biotechnology company developing therapeutic products that target disease-causing proteins for immune diseases, cancer, and aging-related conditions. It employs protein degradation systems to break down these proteins.

SemiFive

Series B in 2022
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions. It develops RISC-V core intellectual property and cloud-based SoC design platforms to create custom systems for consumer and industrial IoT. The company offers end-to-end SoC design capabilities, including platform-based approaches that leverage configurable domain-specific architectures and pre-validated IP pools to accelerate development and reduce cost and risk. It collaborates with foundry partners, notably Samsung Foundry as a SAFETM DSP partner, to provide a one-stop solution for silicon designs. SemiFive aims to help customers realize AI-enabled and data-center oriented workloads through scalable, low-cost silicon solutions.

MORAI

Series B in 2022
Founded in 2018, MORAI specializes in developing simulation platforms for autonomous vehicle testing. Its core offering is a three-dimensional virtual environment that mirrors real-world road conditions, enabling the testing and enhancement of autonomous driving algorithms. The company also provides datasets to support advanced algorithms.

Loadcomplete

Series B in 2022
Loadcomplete is a South Korean developer of social and mobile games, founded in December 2009. The company specializes in creating engaging games for light-core to mid-core audiences, utilizing the latest technologies to foster a social gaming environment. Its notable titles include Tap Tap Heroes, Disco Panda, Bumping Bears, Play Kale, Trino, and Blue Heart, all available on iOS and Android platforms. Through its innovative approach, Loadcomplete aims to provide enjoyable gaming experiences that resonate with enthusiasts.

Hutom

Series B in 2022
Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.

Yeoshin

Series B in 2021
Yeoshin is a skin treatment information platform.

AIONCO KOREA

Series B in 2021
AIONCO KOREA Co., Ltd. is a logistics and air freight service provider based in Seoul, South Korea, established in 2015. The company offers a comprehensive range of services tailored for cross-border eCommerce clients, including competitive item sourcing, multi-channel fulfillment, drop shipments, global wholesale, and logistics solutions. AIONCO KOREA focuses on streamlining supply chains for brands engaged in both direct-to-consumer and wholesale markets. Its offerings also encompass warehousing, distribution logistics, and image production, ensuring a complete solution for managing logistics needs across various channels.

Spatial

Series B in 2021
Spatial Systems, Inc. offers an augmented workplace platform designed to enhance communication and collaboration among users. Founded in 2016 and headquartered in New York, the company enables users to conduct meetings with spatial audio and 3D telepresence, facilitating a more immersive experience. Additionally, Spatial's platform allows for the sharing and organization of various digital content, including 3D models, videos, documents, images, and websites. The focus of the company is to transform how people work by creating a collective computing environment that fosters creativity and productivity. Spatial has attracted investment from notable firms and individuals, positioning itself as a leader in the augmented reality and virtual reality space.

Triple

Series B in 2021
Triple is a travel data services startup that operates a travel booking application connecting travelers with the tourism industry, enabling users to book hotels and restaurants and to access information on weather, currency, directions, translation, time differences and sightseeing spots to help plan and arrange trips abroad.

OncoMyx Therapeutics

Series B in 2021
OncoMyx Therapeutics, Inc., established in 2018 and based in Phoenix, Arizona, specializes in the development of oncolytic immunotherapies. The company's core focus is the myxoma virus (MYXV), a unique oncolytic virus that targets both hematologic and solid tumors. OncoMyx's innovative approach involves a patented systemic delivery method, enabling the virus to be carried by human leukocytes to tumor cells, thereby stimulating an immune response to fight cancer.

OncoMyx Therapeutics

Series B in 2021
OncoMyx Therapeutics, Inc., established in 2018 and based in Phoenix, Arizona, specializes in the development of oncolytic immunotherapies. The company's core focus is the myxoma virus (MYXV), a unique oncolytic virus that targets both hematologic and solid tumors. OncoMyx's innovative approach involves a patented systemic delivery method, enabling the virus to be carried by human leukocytes to tumor cells, thereby stimulating an immune response to fight cancer.

PDC*line Pharma

Series B in 2021
PDC*line Pharma is a French-Belgium clinical-stage biotech company developing active immunotherapies for cancer using its proprietary Plasmacytoid Dendritic Cell line, PDC*line. These therapies aim to stimulate potent and scalable antitumor immune responses.

Otus

Series B in 2021
Otus is a healthcare institute that specializes in advanced eyecare system.

Haoxinqing

Series C in 2021
Haoxinqing is an online medical service platform that specializes in mental psychology and chronic disease management. The company offers remote diagnosis and treatment services, allowing patients to access medical care conveniently from their homes. By focusing on these areas, Haoxinqing aims to enhance patient experience and improve health outcomes, making it easier for individuals to manage their mental health and chronic conditions effectively.

ONDA

Series B in 2021
ONDA is a hospitality technology company based in Seoul, South Korea, specializing in reservation management solutions for small to mid-size hotels and guesthouses both locally and internationally. The company offers a suite of products, including ONDA Plus for reservation management, ONDA Wave for integrated scheduling, and ONDA Star, a comprehensive property management system. Additionally, ONDA Easysell serves as a hotel extranet platform to enhance distribution capabilities. With a focus on optimizing hotel operations and increasing online visibility, ONDA aggregates real-time data from over 40,000 properties and distributes it across 50 online channels, enabling hotels to expand their reach and boost bookings. The company also publishes Magazine ON, which features interviews with accommodation owners and industry insights.

Aulton New Energy

Series B in 2021
Aulton New Energy Automotive Technology Co., Ltd. specializes in developing battery swapping technology for electric vehicles in China. Headquartered in Shanghai, with an additional office in Guangzhou, the company manufactures equipment for quick battery exchanges and manages power stations that facilitate the installation of batteries in taxis and vehicles used for car-hailing services. Aulton also offers energy management services and has created an automated chassis replacement system that allows for the disassembly and installation of batteries in a fully automated environment, significantly reducing the time required for battery replacement to just a few minutes.

Immunobiome

Series B in 2021
Immunobiome is a biotechnology company focused on developing microbiome-based therapeutics aimed at treating challenging diseases, including cancer, autoimmune disorders, allergies, and neurological conditions. By leveraging advanced immunology, bioinformatics, and fundamental microbiome research, the company seeks to create innovative solutions that address conditions often deemed incurable. Its platform specializes in targeted treatments that can help manage intractable immune-related diseases and improve patient outcomes in various health challenges, including organ transplant rejections and inflammation-related issues.

Sellerhub

Series B in 2021
Imagine if you are the online seller, having to sign up and upload your products to 30+ different major commerce websites to maximize your sales. Sellerhub is a web-based commerce suite of solutions where you as the seller sign up, create your online shop, upload product information ONCE then it will be transferred/synched on up to 30+ different major commerce websites at the same time and allow you to manage all their orders in a single integrated dashboard. From building your online shop front, expanding commerce channels, as well as integrating marketing/ad and fulfillment operations, Sellerhub is a one-stop solution for online sellers to manage ALL of your commerce activities in a single dashboard. Key Benefits: 1. Create and manage a beautiful, fully customizable Flagship store online. 2. Single product upload, API-transfer up to 30+ major commerce websites and begin selling simultaneously 3. Fulfillment, Dropshipping, and professional services are also available for you to choose from the full suite of solutions, either directly or through partnership program Established in 2012 with accrued GMV of 1.2 Billion USD, Sellerhub offers a full suite of solutions & services that empower online seller's selling activities, helping you grow revenue and reduce cost/time managing.

Bankware Global

Series B in 2021
Founded in 2010 and headquartered in Seoul, Korea, Bankware Global specializes in the development of banking and financial software systems tailored for various sectors, including retail, corporate, private, treasury, and microfinance banks. With a presence in three countries and four offices, the company serves over 100 financial institutions across seven countries in the Asia Pacific region. Bankware Global is recognized for its expertise in core banking solutions, having supplied its software to five digital banks in markets such as Korea, China, Japan, and Taiwan. The company is distinguished as a leading provider of core banking solutions in Korea, focusing on delivering innovative financial institution products and transaction software to both domestic and international clients.

Connecting

Series B in 2021
Connecting is a real-time voice-talk service company that focuses on facilitating meaningful conversations among individuals. It has developed a social calling application that allows users to define their preferences, including hobbies, age, region, and gender, to enhance the matching process. By leveraging a specialized algorithm, the application connects users with others who share similar interests and criteria, enabling them to engage in hassle-free conversations. This innovative approach aims to create a more personalized and fulfilling social interaction experience for its users.

Kilala

Series B in 2021
Kilala has a product line of color pupils and its surrounding areas to meet the full range of needs of customers.

Eyevensys

Series B in 2021
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.

Cell in Cells

Series B in 2021
Cell in Cells is a biotechnology company focused on advancing regenerative medicine through its innovative cell therapy products. Utilizing advanced 3D technology, the company researches and develops novel biopharmaceuticals and cell therapies aimed at improving human health. By harnessing the potential of stem cells, Cell in Cells strives to create effective therapeutic solutions that enable medical professionals to treat a variety of diseases. The company's commitment to innovation positions it at the forefront of regenerative medicine, contributing significantly to the development of treatments designed to restore health and enhance patient outcomes.

Sky Labs

Series B in 2021
Sky Labs is a technology company focused on developing innovative wearable devices for health monitoring, particularly a cuffless ring-type blood pressure monitor and a device known as the Cardio Tracker (CART). The CART is designed for continuous monitoring of atrial fibrillation, a common and often undiagnosed heart condition affecting many individuals over 40. This device can be worn comfortably on any finger and is both waterproof and dustproof, allowing users to wear it throughout their daily activities without interruption. It operates without user intervention, automatically detecting and recording atrial fibrillation, which users can track via a smartphone application. The device aims not only to assist individuals in managing their heart health but also to provide valuable data to healthcare professionals for accurate diagnosis. Sky Labs is currently conducting clinical trials in collaboration with Seoul National University Hospital to validate the performance of its technology, with an initial focus on the atrial fibrillation patient market in Finland, and an extended target market of millions worldwide. The company is also partnering with Bayer to explore further healthcare innovations.

Barogo

Series C in 2021
Founded in Seoul, South Korea in 2014, Barogo operates a last-mile delivery platform that connects businesses and customers. It specializes in two-wheeled logistics, primarily focusing on food delivery services by partnering with various food outlets.

MOTIV Intelligence

Series C in 2021
MOTIV Intelligence is an ad-tech company that focuses on automating the marketing process. The company utilizes user behavioral data collected from mobile devices to deliver personalized advertisements to individuals who visit websites but do not complete a purchase. By leveraging this data, MOTIV Intelligence aims to enhance marketing effectiveness and improve conversion rates for businesses.

Wyatt

Series C in 2021
Wyatt is a technology company specializing in the beauty industry, developing a customer management application platform designed specifically for salons. Their primary product is a beauty salon booking application that facilitates reservations for customers seeking hair and makeup services.

WonderWall

Series B in 2021
WonderWall is an online art learning platform that connects artists and facilitates the sharing of practical knowledge across various creative disciplines. The platform provides access to a diverse range of online videos covering areas such as music, acting, directing, art, photography, design, and cooking. By offering these resources, WonderWall enables learners to acquire new skills and insights from the comfort of their homes, fostering a community of artists eager to enhance their craft.

Epibiotech

Series B in 2021
Epibiotech is a healthcare center that provides hair loss treatment solutions.

Hisense Bio

Series C in 2021
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

CONTEC

Series B in 2021
CONTEC is providing ground station services, satellite image processing, and application services. The company's ground station network supports VHF, UHF, S-Band, and X-Band frequencies for TT&C via high-performance receivers for high data rate reception. They especially focus on applications for urban change detection of smart cities and aim to provide the best service possible for local governments and therefore contribute to urban development. Contec's main goal of building a global ground station network and operating its own Earth observation satellites.

Modusign

Series B in 2021
Modusign is a technology company specializing in digital contract signing. Its platform enables businesses to sign contracts electronically, streamlining the process and reducing the need for physical meetings.

Onul-Hoi

Series B in 2021
Onul-Hoi operates a mobile commerce and online food delivery platform that enables same-day delivery of fresh fish and other seafood directly from domestic fisheries. The platform sources seafood in season from local fisheries and offers a variety of fresh products and prepared seafood dishes for home delivery.

Trenbe

Series B in 2021
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.

Hutom

Series B in 2021
Hutom is a surgical service platform that leverages digital innovation to enhance the diagnosis and management of surgical procedures. The company specializes in robotics and laparoscopic surgery, offering an interactive platform that includes analytical diagnosis tailored to individual patient needs. Hutom's technology encompasses surgical video processing, recognition, analysis, and predictive capabilities, allowing for a simulated examination of surgeries. Additionally, it provides 3D anatomical images and AI-based surgical analysis reports, which aid medical professionals in efficiently managing patient complications and improving surgical methods. Through its comprehensive data platform, Hutom aims to positively impact the quality of surgical care.

Univercells

Series C in 2020
Univercells is a company specializing in high-density, low-cost biomanufacturing solutions aimed at enhancing the production of biologics, including antibodies, proteins, and vaccines. The company leverages innovative engineering and proprietary technologies, such as single-use systems and continuous process intensification, to significantly reduce capital investments by over 75% and the cost of goods by up to 90%. Univercells offers a range of services, including scale-X hydro, scale-X carbo, and NevoLine, which support both research and development and commercial-scale production of biologics. Additionally, the company provides integrated services like equipment confirmation, capacity and facility design, and bioprocess excellence, facilitating the scalability of cell and gene therapy manufacturers from clinical trials to commercial manufacturing. Through its commitment to making biologics more accessible and affordable, Univercells addresses critical global health challenges.

CHAI

Series B in 2020
CHAI is a company focused on developing infrastructure technologies aimed at enhancing the efficiency of the digital economy. It offers a fintech platform that includes a debit card, a merchant-facing payment API, and an e-wallet that utilizes blockchain technology. This platform allows merchants and individual users to integrate a diverse array of payment options quickly and easily, often in less than an hour. Users can pay for items online by linking their bank accounts, streamlining the payment process. Through its innovative solutions, CHAI aims to facilitate seamless financial transactions and improve the overall digital payment landscape.

Humanscape

Series B in 2020
Founded in 2016, Humanscape specializes in blockchain-based health data platforms. It collects comprehensive patient health data, including genotype, clinical, and phenotype information, to facilitate drug discovery and improve treatments for intractable and rare diseases.

MegazoneCloud

Series B in 2020
MegazoneCloud, established in 2018 as a spin-off from Megazone Corporation, is headquartered in Seoul, South Korea. The company specializes in providing a wide array of cloud adoption and consulting services, including implementation, enterprise support, management, cost optimization, and education. With a strong partnership with Amazon Web Services and over 100 global technology partners, MegazoneCloud has built a reputation as the largest premier consulting partner of AWS in the Asia Pacific region. The company has successfully served more than 1,500 clients, including major enterprises such as Samsung, LG, and Lotte Group, by facilitating their digital transformation through tailored cloud solutions. Additionally, MegazoneCloud operates offices in Palo Alto, Tokyo, Shanghai, Hong Kong, and Hanoi, reflecting its commitment to expanding its global presence and supporting businesses in optimizing their processes and managing their cloud needs effectively.

Wave

Series B in 2020
Wave Corporation, founded in 2018 and based in South Korea, develops a mobile video chat application designed to enhance social interactions among users. The application enables individuals to create chat rooms where they can engage in group video chats, play live party games, watch video clips, read webtoons, and share photos. By facilitating these activities, Wave aims to reduce the distance between people, allowing friends to connect and interact in a more engaging and entertaining manner.

Prokarium

Series B in 2020
Prokarium is a biopharmaceutical company developing microbial immunotherapy and cancer vaccines through a synthetic biology platform. It focuses on immuno-oncology programs designed to evoke durable antitumor responses by re-engineering biological processes to stimulate the immune system. The lead program targets bladder cancer, aiming to transform treatment by orchestrating immune-driven, long-lasting antitumor effects.

EVOS Esports

Series B in 2020
EVOS Esports is an eSports organization focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. The company provides essential infrastructure to support professional players and content creators, fostering an environment that promotes professionalism across various competitive gaming disciplines. EVOS Esports offers a comprehensive structure for its teams, which includes in-game coaching, dedicated training facilities, and mental wellness support. This commitment to player development and well-being positions EVOS Esports as a significant player in the rapidly evolving eSports industry.

Virogin Biotech

Series C in 2020
Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, specializes in the development of oncolytic virus therapeutics aimed at treating cancer. The company utilizes its innovative Synerlyticâ„¢ technical platform to enhance cancer treatment through novel immunotherapy approaches. Virogin's technology focuses on leveraging immunological principles to stimulate anticancer and antitumor immunity. By harnessing a robust and transient antiviral immune response, the company aims to improve systemic antitumor immunity via synergistic interactions with multiple therapeutic payloads. Virogin is dedicated to advancing its position as a leader in the field of immuno-oncology.

Cashkaro

Series B in 2020
Cashkaro is an Indian cashback and coupons site. They are backed by Mr. Ratan Tata and Indian VC firms, Kalaari Capital. With over two million registered users, CashKaro is a one stop destination for savings across 1500+ ecommerce sites like Amazon.in, Flipkart, Nykaa, Ajio, etc.

Gaussian Robot

Series B in 2020
Gaussian Robot is a company based in Shanghai, China, that specializes in the development and manufacturing of commercial automatic sweeping robots. Founded in 2013, the company offers a range of products designed for various applications, including commercial cleaning robots, unmanned sanitation vehicles, security robot solutions, and building distribution robots. Additionally, Gaussian Robot provides autonomous positioning navigation modules to enhance the functionality of its robotic solutions. Through its innovative approach, the company aims to improve efficiency and effectiveness in commercial cleaning and service automation.

Hidden Sequence

Series B in 2020
Hidden Sequence is a production company specializing in drama, film, and TV productions. It focuses on creating original content across various genres, providing opportunities for local artists.

Grip

Series B in 2020
Grip is a mobile application that offers to sell products, update stories, go online and chat communication to sellers.

G2GBIO

Series B in 2020
G2GBIO specializes in biotechnology, focusing on the development and supply of sustained-release pharmaceuticals using its proprietary microsphere technology (InnoLAMP). The company aims to improve patient outcomes globally by extending drug half-life and enhancing delivery systems.

MACHBASE

Series C in 2020
Machbase Inc specializes in providing a columnar database management system designed to process time series log data generated by various machines within IT infrastructures, particularly in the context of the Internet of Things (IoT). The company offers different editions of its software, including an embedded edition for applications such as unified threat management and factory automation, and a standard edition focused on real-time data analysis for security management and energy management systems. Machbase's solutions enable the collection, storage, indexing, retrieval, analysis, and visualization of big data in real-time, catering to industries such as steel, automotive, pharmaceuticals, and logistics. Founded in 2016 and based in San Jose, California, Machbase aims to enhance corporate productivity by delivering integrated information management solutions that support quick adaptation to process innovations and operational changes.

eBrace

Series B in 2020
eBrace is a company focused on the research, development, and production of digital 3D printing technology specifically tailored for orthodontics. The firm specializes in creating innovative solutions for dental applications, including bracketless invisible appliances, customized lingual invisible appliances, and dentures. By leveraging advanced 3D printing techniques, eBrace aims to deliver precise and detailed dental products that meet the needs of both practitioners and patients.

Laundrygo

Series B in 2020
Laundrygo is an on-demand laundry service that offers subscription-based laundry cleaning solutions. The company focuses on delivering a convenient and efficient alternative to traditional laundry services by ensuring that customers receive their cleaned laundry within one day. By providing this rapid turnaround at a lower cost than conventional laundry shops, Laundrygo aims to enhance the customer experience and eliminate the hassle often associated with laundry tasks.

Laserssel

Series C in 2020
Laserssel Co Ltd specializes in the manufacturing and distribution of advanced optical technologies, including beam-shaping optics, optical lasers, laser selective reflow systems, and laser compression bonders. The company serves a diverse range of sectors, such as semiconductor manufacturing, high-end displays, automotive applications, consumer electronics, military technologies, and industrial processes. By providing innovative solutions in laser technology, Laserssel supports the growing demands of these industries with its cutting-edge products.

Medizen Humancare

Series B in 2020
Medizen Humancare, founded in 2012 and headquartered in Seoul, South Korea, is a research company specializing in genomic analysis to predict individual disease risks. The company offers services such as M-CHECK, which analyzes patients' genetic risk for specific diseases using gene chips or analysis kits, and MELTHY (DTC), a DNA analysis service. Medizen Humancare's work involves acquiring disease-specific genome contents, identifying new drug candidate genes, and developing preventive measures, with a focus on guiding disease prevention and extending healthy life spans through personalized genetic insights.

Rabbit Care

Series B in 2020
Rabbit Care operates a financial platform offering various insurance services including automotive, health, life, and corporate. It facilitates payments through multiple channels, aiming to meet business needs and enhance customer experiences via digital platforms and efficient customer care centers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.